BioCentury
ARTICLE | Company News

NovaDel, Suda deal

August 19, 2013 7:00 AM UTC

NovaDel completed the sale of "substantially all" of its assets - including its NovaMist sublingual delivery technology - to Suda for an upfront payment of $400,000 plus 50 million shares of Suda stoc...